FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912379160> ?p ?o ?g. }

• W2912379160 endingPage "760" @default.
• W2912379160 startingPage "749" @default.
• W2912379160 abstract "This 24-week, multicenter, randomized, exploratory, comparative, open-label, phase-IV study assessed the safety and efficacy of prolonged-release tacrolimus (PR-T) with reduced-dose versus standard-dose corticosteroids in stable kidney transplant recipients in Korea after converting from cyclosporine-based therapy.At baseline, patients were converted from cyclosporine-based to PR-T-based immunosuppression and randomized (1:1) to receive either corticosteroids maintained at prestudy dose (standard-dose group) or tapered from week 4 to 50% of the prestudy dose by week 12 (reduced-dose group). Patients were seen at baseline and weeks 1, 4, 12, and 24. The primary endpoint was change in estimated glomerular filtration rate (Modification-of-Diet-in-Renal-Disease-4) between baseline and week 24. Secondary endpoints included either acute rejection or patient-reported satisfaction with PR-T. Adverse events (AEs) were recorded.Overall, 150 patients were randomized into a reduced-dose group (n = 73) and a standard-dose group (n = 77). At week 24, mean ± standard deviation for corticosteroid dose was 2.5 ± 0.9 mg and 5.0 ± 1.3 mg, respectively. Mean change in estimated glomerular filtration rate from baseline to week 24 was +1.5 ± 9.1 mL/min/1.73 m2 (P = .1567) and +3.4 ± 10.6 mL/min/1.73 m2 (P = .0065), respectively, and not significantly different between groups. There were no acute rejection episodes. Most respondents (>70%) considered PR-T more convenient than cyclosporine. AE incidence was similar between groups. The most common AEs experienced by ≥3% of patients in either treatment group were gastrointestinal events (20.8% and 28.6% of patients receiving reduced- and standard-dose corticosteroids, respectively). Most AEs in both treatment groups were mild or moderate in severity.Renal function was maintained following conversion from cyclosporine to PR-T, irrespective of corticosteroid regimen; PR-T enables reduced corticosteroid dosage." @default.
• W2912379160 created "2019-02-21" @default.
• W2912379160 creator A5000923461 @default.
• W2912379160 creator A5035050815 @default.
• W2912379160 creator A5047593737 @default.
• W2912379160 creator A5050440190 @default.
• W2912379160 creator A5054749859 @default.
• W2912379160 creator A5054801119 @default.
• W2912379160 creator A5054972905 @default.
• W2912379160 creator A5058252132 @default.
• W2912379160 creator A5058946620 @default.
• W2912379160 creator A5059260618 @default.
• W2912379160 creator A5070929632 @default.
• W2912379160 creator A5076970428 @default.
• W2912379160 creator A5079818144 @default.
• W2912379160 creator A5080009275 @default.
• W2912379160 creator A5080598138 @default.
• W2912379160 creator A5081261045 @default.
• W2912379160 creator A5083471709 @default.
• W2912379160 creator A5088817148 @default.
• W2912379160 creator A5040046087 @default.
• W2912379160 date "2019-04-01" @default.
• W2912379160 modified "2023-09-23" @default.
• W2912379160 title "Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids" @default.
• W2912379160 cites W1515616426 @default.
• W2912379160 cites W166739738 @default.
• W2912379160 cites W1754287689 @default.
• W2912379160 cites W1914876920 @default.
• W2912379160 cites W1929309318 @default.
• W2912379160 cites W1964040862 @default.
• W2912379160 cites W1970984728 @default.
• W2912379160 cites W1992241917 @default.
• W2912379160 cites W1996147982 @default.
• W2912379160 cites W2008578164 @default.
• W2912379160 cites W2018384104 @default.
• W2912379160 cites W2022383942 @default.
• W2912379160 cites W2026860062 @default.
• W2912379160 cites W2046450640 @default.
• W2912379160 cites W2061578494 @default.
• W2912379160 cites W2078939327 @default.
• W2912379160 cites W2085722449 @default.
• W2912379160 cites W2098773501 @default.
• W2912379160 cites W2115561794 @default.
• W2912379160 cites W2126734393 @default.
• W2912379160 cites W2127001878 @default.
• W2912379160 cites W2137873612 @default.
• W2912379160 cites W2142288396 @default.
• W2912379160 cites W2146000776 @default.
• W2912379160 cites W2162771491 @default.
• W2912379160 cites W2565648189 @default.
• W2912379160 cites W2917257812 @default.
• W2912379160 doi "https://doi.org/10.1016/j.transproceed.2019.01.057" @default.
• W2912379160 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30979460" @default.
• W2912379160 hasPublicationYear "2019" @default.
• W2912379160 type Work @default.
• W2912379160 sameAs 2912379160 @default.
• W2912379160 citedByCount "0" @default.
• W2912379160 crossrefType "journal-article" @default.
• W2912379160 hasAuthorship W2912379160A5000923461 @default.
• W2912379160 hasAuthorship W2912379160A5035050815 @default.
• W2912379160 hasAuthorship W2912379160A5040046087 @default.
• W2912379160 hasAuthorship W2912379160A5047593737 @default.
• W2912379160 hasAuthorship W2912379160A5050440190 @default.
• W2912379160 hasAuthorship W2912379160A5054749859 @default.
• W2912379160 hasAuthorship W2912379160A5054801119 @default.
• W2912379160 hasAuthorship W2912379160A5054972905 @default.
• W2912379160 hasAuthorship W2912379160A5058252132 @default.
• W2912379160 hasAuthorship W2912379160A5058946620 @default.
• W2912379160 hasAuthorship W2912379160A5059260618 @default.
• W2912379160 hasAuthorship W2912379160A5070929632 @default.
• W2912379160 hasAuthorship W2912379160A5076970428 @default.
• W2912379160 hasAuthorship W2912379160A5079818144 @default.
• W2912379160 hasAuthorship W2912379160A5080009275 @default.
• W2912379160 hasAuthorship W2912379160A5080598138 @default.
• W2912379160 hasAuthorship W2912379160A5081261045 @default.
• W2912379160 hasAuthorship W2912379160A5083471709 @default.
• W2912379160 hasAuthorship W2912379160A5088817148 @default.
• W2912379160 hasBestOaLocation W29123791601 @default.
• W2912379160 hasConcept C126322002 @default.
• W2912379160 hasConcept C126894567 @default.
• W2912379160 hasConcept C141071460 @default.
• W2912379160 hasConcept C159641895 @default.
• W2912379160 hasConcept C168563851 @default.
• W2912379160 hasConcept C197934379 @default.
• W2912379160 hasConcept C203092338 @default.
• W2912379160 hasConcept C2776804153 @default.
• W2912379160 hasConcept C2778653478 @default.
• W2912379160 hasConcept C2780252810 @default.
• W2912379160 hasConcept C2909675724 @default.
• W2912379160 hasConcept C2911091166 @default.
• W2912379160 hasConcept C71924100 @default.
• W2912379160 hasConcept C90924648 @default.
• W2912379160 hasConceptScore W2912379160C126322002 @default.
• W2912379160 hasConceptScore W2912379160C126894567 @default.
• W2912379160 hasConceptScore W2912379160C141071460 @default.
• W2912379160 hasConceptScore W2912379160C159641895 @default.
• W2912379160 hasConceptScore W2912379160C168563851 @default.
• W2912379160 hasConceptScore W2912379160C197934379 @default.

• next